Dr. Reddy's Laboratories Limited (RDDA) — Free Cash Flow Generation Index
Dr. Reddy's Laboratories Limited (RDDA) has a Free Cash Flow Generation Index of 0.33x as of December 2025. Free cash flow of €3.59 Billion represents 0% of operating cash flow (€10.91 Billion). Explore RDDA capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Dr. Reddy's Laboratories Limited Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Dr. Reddy's Laboratories Limited across 9 annual periods. For the full cash flow conversion analysis, see Dr. Reddy's Laboratories Limited (RDDA) cash flow conversion.
Annual Free Cash Flow Generation for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year Free Cash Flow Generation Index for Dr. Reddy's Laboratories Limited. Check Dr. Reddy's Laboratories Limited (RDDA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | €12.03 Billion | €46.43 Billion | €34.40 Billion | ▼ -34.6% |
| 2024 | 0.40x | €18.00 Billion | €45.43 Billion | €27.43 Billion | ▼ -41.7% |
| 2023 | 0.68x | €40.01 Billion | €58.88 Billion | €18.87 Billion | ▲ +110.9% |
| 2022 | 0.32x | €9.06 Billion | €28.11 Billion | €14.66 Billion | ▼ -50.3% |
| 2021 | 0.65x | €23.14 Billion | €35.70 Billion | €9.74 Billion | ▼ -18.5% |
| 2020 | 0.80x | €23.73 Billion | €29.84 Billion | €4.85 Billion | ▲ +7.6% |
| 2019 | 0.74x | €21.21 Billion | €28.70 Billion | €6.96 Billion | ▲ +90.7% |
| 2018 | 0.39x | €6.99 Billion | €18.03 Billion | €9.29 Billion | ▼ -75.3% |
| 2017 | 1.57x | €33.79 Billion | €21.51 Billion | €12.28 Billion | — |